Risks and benefits of nucleosides before and after liver transplantation

被引：1
作者：
Tillmann, HL
Klempnauer, J
Manns, MP
机构：
[1] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, D-30625 Hannover, Germany
[2] Hannover Med Sch, Dept Visceral & Transplantsurg, D-30625 Hannover, Germany
来源：
TRANSPLANTATION PROCEEDINGS | 2003年 / 35卷 / 06期
关键词：
D O I：
10.1016/S0041-1345(03)00674-2
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：2086 / 2087
页数：2
相关论文
共 28 条
[1]  
BELLE SH, 1995, CLIN TRANSPL, V19
[2]   Selection of hepatitis B virus polymerase mutants with enhanced replication by lamivudine treatment after liver transplantation [J].
Bock, CT ;
Tillmann, HL ;
Torresi, J ;
Klempnauer, J ;
Locarnini, S ;
Manns, MP ;
Trautwein, C .
GASTROENTEROLOGY, 2002, 122 (02) :264-273
[3]   Severe clinical course of de novo hepatitis B infection after liver transplantation [J].
Crespo, J ;
Fábrega, E ;
Casafont, F ;
Rivero, M ;
de las Heras, G ;
de la Peña, J ;
de la Cruz, F ;
Pons-Romero, F .
LIVER TRANSPLANTATION AND SURGERY, 1999, 5 (03) :175-183
[4]   De novo hepatitis B infection after liver transplantation: Source of disease, incidence, and impact [J].
Fabia, R ;
Levy, MF ;
Crippin, J ;
Tillery, W ;
Netto, GJ ;
Aguanno, J ;
Dysert, P ;
Goldstein, RM ;
Husberg, BS ;
Gonwa, TA ;
Klintmalm, GB .
LIVER TRANSPLANTATION AND SURGERY, 1998, 4 (02) :119-127
[5]  
Gish RG, 1996, HEPATOLOGY, V23, P1
[6]  
Kruger M, 1996, Liver Transpl Surg, V2, P253, DOI 10.1002/lt.500020402
[7]   Lamivudine for chronic delta hepatitis [J].
Lau, DTY ;
Doo, E ;
Park, Y ;
Kleiner, DE ;
Schmid, P ;
Kuhns, MC ;
Hoofnagle, JH .
HEPATOLOGY, 1999, 30 (02) :546-549
[8]   Lamivudine is effective for the treatment of reactivation of hepatitis B virus and fulminant hepatic failure in renal transplant recipients [J].
Lee, WC ;
Wu, MJ ;
Cheng, CH ;
Chen, CH ;
Shu, KH ;
Lian, JD .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2001, 38 (05) :1074-1081
[9]   Monitoring drug resistance in chronic hepatitis B virus (HBV)-infected patients during lamivudine therapy: Evaluation of performance of INNO-LiPA HBV DR assay [J].
Lok, ASF ;
Zoulim, F ;
Locarnini, S ;
Mangia, A ;
Niro, G ;
Decraemer, H ;
Maertens, G ;
Hulstaert, F ;
De Vreese, K ;
Sablon, E .
JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (10) :3729-3734
[10]   LIVER-TRANSPLANTATION IN HBS-ANTIGEN (HBSAG) CARRIERS - PREVENTION OF HEPATITIS-B VIRUS (HBV) RECURRENCE BY PASSIVE-IMMUNIZATION [J].
MULLER, R ;
GUBERNATIS, G ;
FARLE, M ;
NIEHOFF, G ;
KLEIN, H ;
WITTEKIND, C ;
TUSCH, G ;
LAUTZ, HU ;
BOKER, K ;
STANGEL, W ;
PICHLMAYR, R .
JOURNAL OF HEPATOLOGY, 1991, 13 (01) :90-96
123